Anonymous ID: 0b2d57 April 23, 2020, 5:43 p.m. No.8902871   ๐Ÿ—„๏ธ.is ๐Ÿ”—kun   >>2898 >>3048 >>3108 >>3192

Novavax Appoints New Vice President of Vaccine Research

 

MALVERN, Pa., Feb. 2 /PRNewswire-FirstCall/ โ€“ Novavax, Inc. (Nasdaq: NVAX) today announced the appointment of Rick A. Bright, Ph. D. to the newly created position of Vice President, Vaccine Research. Dr. Bright will report directly to Dr. Rahul Singhvi, President and CEO of Novavax.

 

"We are delighted to welcome Dr. Rick Bright to lead our Company's very active vaccine research division,"

 

Novavax, Inc. is a clinical-stage vaccine company headquartered in Gaithersburg, Maryland with additional facilities in Rockville, Maryland and Uppsala, Sweden.

Novavax received a US$89 million research grant from the

Bill and Melinda Gates Foundation for development of vaccines for maternal immunization

.Wikipedia

 

https://ir.novavax.com/news-releases/news-release-details/novavax-appoints-new-vice-president-vaccine-research

 

https://en.wikipedia.org/wiki/Novavax

PB

>>8901948 Ousted' US vaccine expert Rick Bright to file whistleblower complaint